Liver transplantation for hilar cholangiocarcinoma;Lebertransplantation beim hilären cholangiokarzinom

Chirurg

Volumn 83, Issue 3, 2012, Pages 229-237

  Rauchfuss F ^a   Utess F ^a   Schule S ^a   Dittmar, Y ^a   Scheuerlein, H ^a   Settmacher, U ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Cholangiocarcinoma; Immunosuppression; Klatskin tumor; Liver transplantation; Neoadjuvant therapy

Indexed keywords

ADJUVANT THERAPY; ARTICLE; BILE DUCT TUMOR; CANCER STAGING; HEPATIC DUCT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KLATSKIN TUMOR; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPHADENECTOMY; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

BILE DUCT NEOPLASMS; COMBINED MODALITY THERAPY; HEPATECTOMY; HEPATIC DUCT, COMMON; HUMANS; IMMUNOSUPPRESSION; KLATSKIN'S TUMOR; LIVER TRANSPLANTATION; LYMPH NODE EXCISION; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 84858008789     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-011-2178-5     Document Type: Article

References (57)

1. Seehofer D, Thelen A, Neumann UP et al (2009) Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cho-langiocarcinoma: long-term results. Liver Transpl 15:1499-1507
2. Starzl TE, Porter KA, Putnam CW (1997) Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet 142:487-505
3. Shaib Y, El-Serag HB (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115-125
4. Broomé U, Löfberg R, Veress B, Eriksson LS (1995) Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22:1404-1408
5. Karlsen TH, Schrumpf E, Boberg KM (2010) Primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 24:655-666
6. Blechacz BRA, Gores GJ (2008) Cholangiocarcinoma. Clin Liver Dis 12:131-150
7. De Kerckhove L, De Meyer M, Verbaandert C et al (2006) The place of liver transplantation in Caroli's disease and syndrome. Transpl Int 19:381-388
8. Ulrich F, Pratschke J, Pascher A (2008) Long-term outcome of liver resection and transplantation for caroli disease and syndrome. Ann Surg 247:357-364
9. Jarnagin WR, Fong Y, de Matteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507-519
10. Deoliveira ML, Schulick RD, Nimura Y et al (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53:1363-1371
11. Cucchetti A, Vitale A, Gaudio MD et al (2010) Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am JTransplant 10:619-627
12. Zhang Y, Uchida M, Abe T et-al (1999) Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CTand dynamic MRI. J Comput Assist To-mogr 23:670
13. Manfredi R, Barbaro B, Masselli G et al (2004) Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 24:155-164
14. Rösch T, Meining A, Frühmorgen S et al (2002) A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 55:870-876
15. Kato T, Tsukamoto E, Kuge Y et al (2002) Clinical role of 18 F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 29:1047-1054
16. Breitenstein S, Apestegui C, Clavien PA (2008) Positron emission tomography (PET) for cholangiocarcinoma. HPB (Oxford) 10:120-121
17. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303-1314
18. Heimbach JK, Gores GJ, Haddock MG et al (2006) Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82:1703-1707
19. Fan L, He F, Liu H et al (2011) CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 11:320
20. Boonjaraspinyo S, Boonmars T, Kaewkes S et al (2011) Down-regulated expression of hsp70 in correlation with clinicopathology of cholangiocarcinoma. Pathol Oncol Res 13 [Epub ahead of print]
21. Subimerb C, Pinlaor S, Khuntikeo N et al (2010) Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Mol Med Report 3:597-605
22. Tamada K, Ushio J, Sugano K (2011) Endoscopic diagnosis of extrahepatic bile duct carcinoma: advances and current limitations. World J Clin Oncol 2:203-216
23. Heimbach JK, Sanchez W, Rosen CB, Gores GJ (2011) Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford) 3:356-360
24. Hong JC, Petrowsky H, Kaldas FM et al (2011) Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma. J Am Coll Surg 212:514-21
25. Baere T de, Denys A, Madoff DC (2007) Preoperative portal vein embolization: indications and technical considerations. Tech Vasc Interv Radiol 10:67-78
26. Makuuchi M, Donadon M, Torzilli G (2008) Hepatic resection for hepatocellular carcinoma in cirrhosis. Ann ItalChir 79:111-115
27. Stockmann M, Lock JF, Malinowski M et al (2010) The LiMAxtest: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 12:139-146
28. Neuhaus P, Thelen A, Jonas S et al (2011) Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol [Epub ahead of print]
29. Bundesärztekammer (2010) Bundesärztekammer-Richtlinien zurTransplantationsmedizin. Bundesarztekammer
30. Schlitt HJ, Loss M, Scherer MN et al (2011) Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres. Z Gastroenterol 49:30-38
31. Biggins SW, Bambha K (2006) MELD-based liver allocation: who is underserved? Semin Liver Dis 26:211-220
32. Gores GJ, Gish RG, Sudan D, Rosen CB (2006) MELD exception study group. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 12(Suppl3):95-97
33. Pinson CW, Moore DE (2003) Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) 5:203-205
34. Jeyarajah DR, Klintmalm GB (1998) Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg 5:48-51
35. Robles R, Figueras J, Turrión VS et al (2004) Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 239:265-271
36. Heimbach JK, Gores GJ, Haddock MG et al (2004) Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24:201-207
37. Mantel HTJ, Rosen CB, Heimbach JK et al (2007) Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 10:1372-1381
38. Grossman EJ, Millis JM (2010) Liver transplantation for non-hepatocellular carcinoma malignancy: indications, limitations, and analysis of the current literature. Liver Transpl 8:930-942
39. Settmacher U, Götz M, Rahmel A et al (2011) Living donor liver transplantation in adults in the MELD era in Germany-a multi-center retrospective analysis. Transpl Int 24:904-911
40. Jonas S, Mittler J, Pascher A et al (2005) Extended indications in living-donor liver transplantation: bile duct cancer. Transplantation 80(Suppl 1):101-104
41. Neuhaus P, Jonas S et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230:808-819
42. Starzl TE, Todo S, Tzakis A et al (1989) Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 210:374-386
43. Jonas S, Kling N, Guckelberger O et al (1998) Orthotopic livertransplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma. First long-terms results. Transpl Int 11(Suppl 1):206-208
44. Rea DJ, Heimbach JK, Rosen CB et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effectivethan resection for hilar cholangiocarcinoma. Ann Surg 242:451
45. Wu Y, Johlin FC, Rayhill SC et al (2008) Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl 3:279-286
46. Soejima Y, Ueda S, Sanefuji K et al (2008) Sequential pancreaticoduodenectomy after living donor liver transplantation for cholangiocarcinoma. Am J Transplant 10:2158-2162
47. Alessiani M, Tzakis A, Todo S et al (1995) Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1801:1-9
48. Farmer DG, Shaked A, Colonna JO et al (1993) Radical resection combined with livertransplantation for foregut tumors. Am Surg 59:806-812
49. Rosen CB, Heimbach JK, Gores GJ (2010) Liver transplantation for cholangiocarcinoma. Transpl Int 23:692-697
50. Heimbach JK (2008) Successful livertransplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol 24:384-388
51. Sotiropoulos GC, Lang H, Niebel W et al (2004) 10-year tumor-free survival after intraoperative radiation therapy and secondary livertransplantation for hilar cholangiocarcinoma. Transplantation 77:1625
52. Gu J, Bai J, Shi X et al (2011) Efficacy and safety of liver transplantation for patients with cholangiocarcinoma: a systematic review and meta-analysis. Int J Cancer [Epub ahead of print]
53. Rizell M, Andersson M, Cahlin C et al (2008) Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer. Int J Clin Oncol 13:66-70
54. Castroagudín JF, Molina E, Tomé S et al (2009) Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence. Transplant Proc 41:1003-1004
55. Shimoda M (2001) Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl 7:1023-1033
56. Meyer CG, Penn I, James L (2000) Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 69:1633-1637
57. Soderdahl G, Barkholt L, Hentschke P et al (2003) Livertransplantation followed by adjuvant non-myeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans. Transplantation 75:1061-1066